Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea ... index (BMI) and apnea-hypopnea index (AHI) values ...

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to find out more information.

Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems a ...

The Link Between Obesity and Obstructive Sleep Apnea Obstructive sleep apnea ... the drug’s effectiveness was measured by the apnea-hypopnea index (AHI), which tracks the frequency of breathing ...

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

“This is a major step forward for patients with obstructive sleep apnea ... Zepbound reduced apnea-hypopnea index events by an average of 25 per hour after one year compared with a ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in Otolaryngology–Head and Neck Surgery reveals that for people with sleep apnea, ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said ... was the change in the apnea hypopnea index (AHI), which tracks how ...